Sterling Capital Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.14K | Buy |
297
+113
| +61% | +$1.2K | ﹤0.01% | 2761 |
|
|
2025
Q1 | $2.77K | Sell |
184
-181
| -50% | -$2.72K | ﹤0.01% | 2454 |
|
|
2024
Q4 | $6.01K | Buy |
365
+324
| +790% | +$5.33K | ﹤0.01% | 2376 |
|
|
2024
Q3 | $1.01K | Buy |
+41
| New | +$1.01K | ﹤0.01% | 2523 |
|
|
2015
Q1 | – | Sell |
-44,916
| Closed | -$1.83M | – | 870 |
|
|
2014
Q4 | $1.83M | Sell |
44,916
-316
| -0.7% | -$12.9K | 0.02% | 430 |
|
|
2014
Q3 | $1.66M | Buy |
45,232
+1,037
| +2% | +$38K | 0.02% | 444 |
|
|
2014
Q2 | $2.05M | Buy |
44,195
+1,063
| +2% | +$49.2K | 0.02% | 341 |
|
|
2014
Q1 | $1.77M | Buy |
43,132
+31,362
| +266% | +$1.29M | 0.02% | 368 |
|
|
2013
Q4 | $449K | Buy |
11,770
+933
| +9% | +$35.6K | ﹤0.01% | 621 |
|
|
2013
Q3 | $259K | Buy |
+10,837
| New | +$259K | ﹤0.01% | 605 |
|